Cargando…
Immunization with mutant HPV16 E7 protein inhibits the growth of TC-1 cells in tumor-bearing mice
Two human papillomavirus (HPV) 16 oncogenic proteins, E6 and E7, are co-expressed in the majority of HPV16-induced cervical cancer cells. Thus, the E6 and E7 proteins are good targets for developing therapeutic vaccines for cervical cancer. In the present study, immunization with the mutant non-tran...
Autores principales: | LI, YAN-LI, MA, ZHONG-LIANG, ZHAO, YUE, ZHANG, JING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356387/ https://www.ncbi.nlm.nih.gov/pubmed/25789055 http://dx.doi.org/10.3892/ol.2015.2911 |
Ejemplares similares
-
Prevention and Inhibition of TC-1 Cell Growth in Tumor
Bearing Mice by HPV16 E7 Protein in Fusion with Shiga
Toxin B-Subunit from shigella dysenteriae
por: Sadraeian, Mohammad, et al.
Publicado: (2013) -
HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023) -
Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor
por: Li, Sijin, et al.
Publicado: (2019) -
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
por: Hu, Zheng, et al.
Publicado: (2014) -
Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor
por: Wang, Shijie, et al.
Publicado: (2017)